Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Country / region: Croatia Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20151
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Kiadis Pharma1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes4
Anemia, Refractory, with Excess of Blasts3
Anemia, Refractory2
Leukemia2
Leukemia, Myelomonocytic, Chronic2
Graft vs Host Disease1
Hematologic Neoplasms1
Leukemia, Myeloid, Acute1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Myelodysplastic-Myeloproliferative Diseases1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.